• LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn

R.D. Solorzano

  • restor3d Completes First Clinical Cases of Fully Personalized 3D-Printed Knee Replacement System
    December 17, 2025

    restor3d Completes First Clinical Cases of Fully Personalized 3D-Printed Knee Replacement System

    R.D. Solorzano
  • Revalia Bio Secures ~$30M Government Contract to Build the Future of Human-First Drug Development
    December 15, 2025

    Revalia Bio Secures ~$30M Government Contract to Build the Future of Human-First Drug Development

    R.D. Solorzano
  • Inside Curi Bio’s Human Tissue Platforms: How They Work, What the $10M Series B Will Accelerate, and Why It Matters
    December 11, 2025

    Inside Curi Bio’s Human Tissue Platforms: How They Work, What the $10M Series B Will Accelerate, and Why It Matters

    R.D. Solorzano
  • Xeltis Secures Nearly €50M to Advance aXess Toward Market Entry as New Data Strengthen Clinical Profile
    December 10, 2025

    Xeltis Secures Nearly €50M to Advance aXess Toward Market Entry as New Data Strengthen Clinical Profile

    R.D. Solorzano
  • From Lab to Eye – A World First: How Precise Bio’s 3D-Printed Corneal Implant Really Works
    December 3, 2025

    From Lab to Eye – A World First: How Precise Bio’s 3D-Printed Corneal Implant Really Works

    R.D. Solorzano
  • The Rise of the Tiger – Tiger BioSciences: Building a Fully Integrated Platform for Regenerative Medicine
    November 28, 2025

    The Rise of the Tiger – Tiger BioSciences: Building a Fully Integrated Platform for Regenerative Medicine

    R.D. Solorzano
  • InSphero Acquires Doppl SA, Expanding Its 3D Cell Culture Portfolio with the Gri3D® Platform
    November 20, 2025

    InSphero Acquires Doppl SA, Expanding Its 3D Cell Culture Portfolio with the Gri3D® Platform

    R.D. Solorzano
  • Tiger Aesthetics Invests in GenesisTissue to Advance Regenerative Breast Reconstruction
    November 17, 2025

    Tiger Aesthetics Invests in GenesisTissue to Advance Regenerative Breast Reconstruction

    R.D. Solorzano
  • The Race to Automate Cell Manufacturing
    November 12, 2025

    The Race to Automate Cell Manufacturing

    R.D. Solorzano
  • Lattice Medical Raises €43M to Transform Post-Cancer Reconstruction and Scale 3D Bioprinting in France
    November 11, 2025

    Lattice Medical Raises €43M to Transform Post-Cancer Reconstruction and Scale 3D Bioprinting in France

    R.D. Solorzano
1 2 3 … 12
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    • The Business of Biofabrication
    • Already have a WordPress.com account? Log in now.
    • The Business of Biofabrication
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar